Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 34951-35000 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT06487156
A Study to Evaluate First-line Ipilimumab + Nivolumab in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
N/ARecruiting
400 participants
Started: Oct 11, 2023 · Completed: Oct 11, 2030
1 condition1 sponsor1 location
NCT06219200
Automatic Voice Analysis for Dysphagia Screening in Neurological Patients
N/ARecruiting
400 participants
Started: Oct 11, 2023 · Completed: Dec 31, 2025
2 conditions2 sponsors2 locations
NCT05978362
Value of Capsular Repair for Latarjet
NARecruiting
86 participants
Started: Oct 11, 2023 · Completed: Dec 31, 2034
1 condition2 sponsors1 location
NCT05724823
Virtual Physical Activity Seated Exercise - Phase 2
NARecruiting
100 participants
Started: Oct 11, 2023 · Completed: Dec 31, 2026
4 conditions3 sponsors5 locations
NCT06333067
Treatment to Lift Facial Lax Skin and Improve Facial Wrinkles Using Precise and Lift Applicators
NARecruiting
100 participants
Started: Oct 11, 2023 · Completed: Nov 1, 2025
1 condition1 sponsor2 locations
NCT06106646
Vitamin C to Decrease Effects of Smoking in Pregnancy on Infant Lung Function (VCSIP) Longer Term Follow Up
N/ARecruiting
225 participants
Started: Oct 11, 2023 · Completed: Aug 31, 2028
4 conditions3 sponsors2 locations
NCT05979337
Brief Interventions in Chronic Migraine
NARecruiting
300 participants
Started: Oct 11, 2023 · Completed: Jan 31, 2027
1 condition2 sponsors1 location
NCT06257290
The Role of Platelet TLRs in Platelet Activation During VTE
N/ARecruiting
100 participants
Started: Oct 11, 2023 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT05932589
Neurophysiologic Biomarkers in Rett Syndrome
N/ARecruiting
202 participants
Started: Oct 11, 2023 · Completed: Mar 31, 2029
3 conditions3 sponsors6 locations
NCT06112340
Extension Study of Two Doses of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED)
PHASE2/PHASE3Recruiting
75 participants
Started: Oct 11, 2023 · Completed: Jun 30, 2026
12 conditions1 sponsor2 locations
NCT06012240
A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata
PHASE3Recruiting
1,500 participants
Started: Oct 11, 2023 · Completed: Jan 31, 2028
1 condition1 sponsor267 locations
NCT05501704
ETHAN - ET for Male BC
PHASE2Recruiting
60 participants
Started: Oct 11, 2023 · Completed: Apr 1, 2036
3 conditions3 sponsors7 locations
NCT05681650
HER2 Targeted HypoSti.CAR-T Cells in HER2 Positive Advanced Solid Tumors
PHASE1/PHASE2Recruiting
30 participants
Started: Oct 11, 2023 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT06085508
Fear of MOVEment After MI and AF - InterneT Patient Education
NARecruiting
14 participants
Started: Oct 11, 2023 · Completed: Feb 29, 2024
3 conditions5 sponsors1 location
NCT06083610
MicroRNA-1 (miRNA-1) and MicroRNA-133a (miRNA-133a) Levels After Acute Exercise in Ultimate Frisbee Athletes
N/ARecruiting
34 participants
Started: Oct 11, 2023 · Completed: May 31, 2024
1 condition1 sponsor1 location
NCT05832229
Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States
PHASE2Recruiting
256 participants
Started: Oct 11, 2023 · Completed: Nov 30, 2028
8 conditions15 sponsors13 locations
NCT06353555
Efficacy of Thyroid Hormone Replacement for Secondary Hypothyroidism Following Intracerebral Hemorrhage
NARecruiting
100 participants
Started: Oct 11, 2023 · Completed: Dec 31, 2025
4 conditions1 sponsor1 location
NCT06455046
Efficacy and Safety of AK104 Combined With Chemotherapy and Recombinant Human Adenovirus 5 Injection in Cervical Cancer
PHASE2Recruiting
37 participants
Started: Oct 11, 2023 · Completed: Oct 10, 2025
1 condition2 sponsors1 location
NCT06022549
Effects of mHealth Message on Metabolic Syndrome and Bone Loss of HIV Infected Persons in Taiwan
N/ARecruiting
400 participants
Started: Oct 11, 2023 · Completed: Jan 31, 2025
1 condition1 sponsor1 location
NCT06386276
Surgical TReatment of Women With Deep ENDometriosis
N/ARecruiting
250 participants
Started: Oct 11, 2023 · Completed: Jun 30, 2029
2 conditions1 sponsor1 location
NCT05922930
Study of TROP2 CAR Engineered IL15-transduced Cord Blood-derived NK Cells Delivered Intraperitoneally for the Management of Platinum Resistant Ovarian Cancer, Mesonephric-like Adenocarcinoma, and Pancreatic Cancer
PHASE1/PHASE2Recruiting
51 participants
Started: Oct 11, 2023 · Completed: Jan 15, 2028
3 conditions1 sponsor1 location
NCT06052098
Transbronchial vs Transthoracic Ablation for Early-stage Peripheral Lung Cancer
NARecruiting
110 participants
Started: Oct 11, 2023 · Completed: Oct 31, 2027
1 condition2 sponsors1 location
NCT06451172
Novel Antisense Oligonucleotide Eye Drops for Treating Antibiotic-Resistant Bacterial Keratitis
EARLY_PHASE1Recruiting
20 participants
Started: Oct 11, 2023 · Completed: Oct 31, 2026
10 conditions2 sponsors1 location
NCT05936333
Exploration of Allograft Humoral Rejection in Chronic Histiocytic Intervillositis
NARecruiting
200 participants
Started: Oct 11, 2023 · Completed: Oct 11, 2025
4 conditions1 sponsor1 location
NCT06116019
Online Adaptive Radiotherapy Using a Novel Linear Accelerator (ETHOS)
N/ARecruiting
649 participants
Started: Oct 11, 2023 · Completed: Oct 9, 2027
9 conditions1 sponsor1 location
NCT06051955
Evaluation of an Oral Sodium Sulfate Solution for Patients With Prior Difficult or Incomplete Cleansing
NARecruiting
120 participants
Started: Oct 11, 2023 · Completed: Sep 30, 2024
2 conditions2 sponsors2 locations
NCT05959694
A Clinical Trial on the Safety and Efficacy of TQB3909 Tablets in Patients With Recurrent or Refractory Chronic Lymphocytic Leukemia (CLL) /Small Lymphocytic Lymphoma (SLL) .
PHASE1/PHASE2Recruiting
107 participants
Started: Oct 11, 2023 · Completed: Jun 30, 2026
2 conditions1 sponsor25 locations
NCT05362929
Efficacy and Tolerability of a Hybrid Fractional Laser for the Treatment of Acne Scars in Patients With Skin of Color
NARecruiting
46 participants
Started: Oct 11, 2023 · Completed: Sep 30, 2026
3 conditions1 sponsor1 location
NCT06031805
PRostate Olaparib Real World Evidence Study
N/ARecruiting
300 participants
Started: Oct 11, 2023 · Completed: Oct 13, 2028
1 condition1 sponsor63 locations
NCT06628336
Post-Market Observational Study of the HARMONY® Evolution Implants and Instruments
N/ARecruiting
264 participants
Started: Oct 11, 2023 · Completed: Mar 11, 2035
1 condition1 sponsor5 locations
NCT06026267
Efficacy of Conventional Dose Protocol vs Low Dose Protocol Albumin Use in Patients With Cirrhosis and High Risk Spontaneous Bacterial Peritonitis
NARecruiting
300 participants
Started: Oct 10, 2023 · Completed: Dec 31, 2024
2 conditions1 sponsor1 location
NCT06282003
Protective Anesthesiological Management Procedure Imposes Control on Respiratory Comlications
NARecruiting
53 participants
Started: Oct 10, 2023 · Completed: Sep 30, 2024
1 condition6 sponsors1 location
NCT05968456
Complexity and Frailty in Cardiothoracic and Vascular Anesthesia (CAfCA). Prospective Multicentric Observational Study
N/ARecruiting
500 participants
Started: Oct 10, 2023 · Completed: Apr 30, 2024
6 conditions2 sponsors8 locations
NCT06971718
Coronary Bifurcations With Ischaemia and Flow Assessment
N/ARecruiting
24 participants
Started: Oct 10, 2023 · Completed: Jun 1, 2026
1 condition2 sponsors1 location
NCT06368557
Internet-based Cognitive Behavioral Intervention for Adolescents With Anxiety Disorders
NARecruiting
168 participants
Started: Oct 10, 2023 · Completed: Jun 30, 2025
1 condition2 sponsors1 location
NCT05848713
AntiThrombotic Therapy to Ameliorate Clinical Complications in Community Acquired Pneumonia
PHASE3Recruiting
4,000 participants
Started: Oct 10, 2023 · Completed: Mar 31, 2029
1 condition7 sponsors62 locations
NCT06671158
Measurement-Based Care (MBC) Implementation, Effectiveness, and Mechanisms of Change
NARecruiting
90 participants
Started: Oct 10, 2023 · Completed: Dec 31, 2025
2 conditions2 sponsors1 location
NCT05958368
Assessing the Value of Avocados on Glycemic Control in Type 2 Diabetes
NARecruiting
48 participants
Started: Oct 10, 2023 · Completed: Dec 15, 2026
6 conditions4 sponsors1 location
NCT05866835
Validation of a Digitalised Intraoral Protection
NARecruiting
60 participants
Started: Oct 10, 2023 · Completed: Jan 31, 2026
1 condition1 sponsor3 locations
NCT06119815
CO2 Gap Changes Versus Inferior Vena Cava Collapsibility in Relation to Cardiac Index as a Prognostic Value in Septic Shock
NARecruiting
60 participants
Started: Oct 10, 2023 · Completed: Oct 10, 2025
1 condition1 sponsor1 location
NCT06070870
Health Education Approach to Lung Screening
NARecruiting
225 participants
Started: Oct 10, 2023 · Completed: Apr 30, 2026
1 condition2 sponsors3 locations
NCT06316232
DBS and Levodopa for Treating Freezing of Gait in Parkinson's Disease
PHASE4Recruiting
20 participants
Started: Oct 10, 2023 · Completed: Dec 31, 2026
2 conditions2 sponsors1 location
NCT06033430
Effectiveness of Dry Needling in Linear Scar Tissue
NARecruiting
80 participants
Started: Oct 10, 2023 · Completed: Jun 1, 2025
5 conditions1 sponsor2 locations
NCT06086782
Effects of Autogenic and Reciprocal Inhibition on Trapezitis
NARecruiting
42 participants
Started: Oct 10, 2023 · Completed: Dec 31, 2023
1 condition1 sponsor1 location
NCT05867472
Advancing Brain Outcomes in Pediatric Critically Ill Patients Sedated With Volatile AnEsthestic Agents
PHASE3Recruiting
60 participants
Started: Oct 10, 2023 · Completed: Dec 31, 2026
3 conditions2 sponsors3 locations
NCT06948344
Acquirement of Clinical and Genomic Data to Diagnose in Rare Inherited Cardiomyopathy
N/ARecruiting
560 participants
Started: Oct 10, 2023 · Completed: Aug 22, 2028
2 conditions1 sponsor1 location
NCT06667154
Efficacy Analysis of Neoadjuvant Treatment in Lung Cancer Using Low-dose Nivolumab Combined With Chemotherapy
PHASE2Recruiting
33 participants
Started: Oct 10, 2023 · Completed: Oct 31, 2027
2 conditions2 sponsors1 location
NCT06245447
Brain MRI Longitudinal Volumetric Characteristics Associated With Outcomes of CASPR2-Limbic Encephalitis
N/ARecruiting
27 participants
Started: Oct 10, 2023 · Completed: Oct 31, 2024
1 condition1 sponsor1 location
NCT05288855
Voclosporin in Adolescent and Pediatric Subjects With Lupus Nephritis
PHASE3Recruiting
40 participants
Started: Oct 10, 2023 · Completed: Jun 30, 2028
2 conditions1 sponsor7 locations
NCT06245395
Virtual Reality as Distraction Analgesia and Anxiolysis for Pediatric Otolaryngology Procedures
NARecruiting
100 participants
Started: Oct 10, 2023 · Completed: Dec 31, 2024
2 conditions1 sponsor1 location